Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKaraburun, Ahmet Çağrı
dc.contributor.authorGündoğdu-Karaburun, Nalan
dc.contributor.authorYurttaş, Leyla
dc.contributor.authorKayagil, İsmail
dc.contributor.authorDemirayak, Şeref
dc.date.accessioned2019-10-19T14:44:33Z
dc.date.available2019-10-19T14:44:33Z
dc.date.issued2019
dc.identifier.issn1570-1808
dc.identifier.issn1875-628X
dc.identifier.urihttps://dx.doi.org/10.2174/1570180815666180606081042
dc.identifier.urihttps://hdl.handle.net/11421/13550
dc.descriptionWOS: 000459738100002en_US
dc.description.abstractBackground: The synthesis of 2-[3/4-((6-substituted-1-oxo-2,3-dihydro-1H-inden-2ylidene) methyl)phenoxy]-N-(heteroaryl)acetamide derivatives and the investigation of their anticancer activity were studied. Methods: 2-(3/4-Hydroxybenzylidene)-6-substituted-2,3-dihydro-1H-inden-1-ones were reacted with suitable 2-chloroacetamides to give 2-[3/4-((6-substituted-1-oxo-2,3-dihydro-1H-inden-2-ylidene)methyl) phenoxy]-N-(heteroaryl) acetamide derivatives. Results: The structure elucidation of the newly synthesised 16 compounds was performed by IR, 1H-NMR, mass spectroscopic data and elemental analyses. The anticancer screening was carried out in National Cancer Institute (NCI), USA. Conclusion: Compound 3e (2-(3-((6-chloro-1-oxo-2,3-dihydro-1H-inden-2-ylidene) methyl)phenoxy)N-(thiazol-2-yl)acetamide), exhibited highest growth inhibition against the leukaemia (61.47%), non-small cell lung cancer (79.31%) and breast cancer (62.82%) cell lines.en_US
dc.description.sponsorshipAnadolu University, Turkey (BAP) [050301]en_US
dc.description.sponsorshipThis work was supported by Anadolu University, Turkey (BAP Project No: 050301). NCI, USA is gratefully acknowledged for investigating the anticancer activity.en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ LTDen_US
dc.relation.isversionof10.2174/1570180815666180606081042en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnticancer Activityen_US
dc.subjectAurone Analogueen_US
dc.subjectBenzothiazoleacetamideen_US
dc.subject2,3-Dihydro-1H-Inden-1-Oneen_US
dc.subjectThiazoleacetamideen_US
dc.subjectLeukaemiaen_US
dc.titleSynthesis and Anticancer Activity of Some 1H-inden-1-one Substituted (Heteroaryl)Acetamide Derivativesen_US
dc.typearticleen_US
dc.relation.journalLetters in Drug Design & Discoveryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalıen_US
dc.identifier.volume16en_US
dc.identifier.issue2en_US
dc.identifier.startpage111en_US
dc.identifier.endpage118en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorKaraburun, Ahmet Çağrı
dc.contributor.institutionauthorGündoğdu-Karaburun, Nalan
dc.contributor.institutionauthorYurttaş, Leyla
dc.contributor.institutionauthorDemirayak, Şeref


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster